CP-690,550 is being developed as a potential disease-modifying anti-rheumatic drug delivered orally in pill form.
If you suffer from RA, you may be eligible to participate in the ORAL trials.
Apply online or call 866-439-6626.
Do you know someone with RA? Patients are being recruited now for the ORAL trials.